Reata Pharmaceuticals Price History

RETADelisted Stock  USD 109.67  3.31  2.93%   
If you're considering investing in Reata Stock, it is important to understand the factors that can impact its price. As of today, the current price of Reata Pharmaceuticals stands at 109.67, as last reported on the 29th of November, with the highest price reaching 115.23 and the lowest price hitting 109.66 during the day. We have found thirty technical indicators for Reata Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Reata Pharmaceuticals' Semi Deviation of 3.31, coefficient of variation of 1897.93, and Risk Adjusted Performance of 0.0484 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Reata Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
RETA
Based on monthly moving average Reata Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Reata Pharmaceuticals by adding Reata Pharmaceuticals to a well-diversified portfolio.

Reata Pharmaceuticals Stock Price History Chart

There are several ways to analyze Reata Stock price data. The simplest method is using a basic Reata candlestick price chart, which shows Reata Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Reata Stock Price History Data

The price series of Reata Pharmaceuticals for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 33.79 with a coefficient of variation of 8.77. The price distribution for the period has arithmetic mean of 97.61. The median price for the last 90 days is 98.86.
OpenHighLowCloseVolume
11/29/2024
 112.98  115.23  109.66  109.67 
07/24/2023 112.98  115.23  109.66  109.67  351,058 
07/21/2023 110.59  112.23  108.84  110.86  219,671 
07/20/2023 112.91  113.09  109.97  110.11  531,037 
07/19/2023 110.26  113.61  108.04  113.01  602,706 
07/18/2023 111.20  111.20  108.04  109.15  381,582 
07/17/2023 109.40  111.24  108.88  110.47  301,667 
07/14/2023 107.69  110.37  107.69  109.13  346,884 
07/13/2023 109.25  110.72  107.18  107.71  341,874 
07/12/2023 110.00  110.86  107.76  109.04  451,900 
07/11/2023 107.45  109.99  104.82  109.32  570,762 
07/10/2023 104.36  108.61  103.60  107.25  368,087 
07/07/2023 108.00  108.50  103.78  104.37  627,871 
07/06/2023 104.80  108.00  103.18  107.89  683,653 
07/05/2023 102.88  104.58  102.27  103.90  347,677 
07/03/2023 102.00  103.59  101.64  102.88  233,431 
06/30/2023 101.23  104.59  99.91  101.96  693,647 
06/29/2023 100.48  104.79  99.45  100.90  912,118 
06/28/2023 98.03  103.26  94.31  98.83  2,096,237 
06/27/2023 91.54  92.89  88.80  92.39  521,617 
06/26/2023 93.16  94.52  88.90  90.01  434,068 
06/23/2023 96.18  96.41  92.91  93.79  804,054 
06/22/2023 95.92  99.53  94.51  97.11  497,153 
06/21/2023 93.68  96.39  92.22  95.76  447,527 
06/20/2023 92.04  94.10  90.70  93.15  345,514 
06/16/2023 96.89  97.67  91.36  93.38  1,454,279 
06/15/2023 100.96  100.99  87.66  93.61  2,254,033 
06/14/2023 104.31  105.45  100.21  102.22  445,800 
06/13/2023 98.30  105.55  98.30  104.31  936,200 
06/12/2023 96.00  99.98  95.46  99.12  970,002 
06/09/2023 93.96  94.86  93.06  93.80  619,164 
06/08/2023 94.09  95.07  93.21  94.10  289,816 
06/07/2023 94.11  95.44  92.58  93.61  343,062 
06/06/2023 91.96  94.75  91.77  93.93  399,742 
06/05/2023 91.90  94.50  90.46  92.08  356,613 
06/02/2023 91.14  93.66  89.62  93.02  491,041 
06/01/2023 90.66  92.49  88.59  91.13  502,600 
05/31/2023 89.72  90.98  87.82  90.05  697,424 
05/30/2023 92.00  92.51  88.78  89.70  797,728 
05/26/2023 92.54  94.20  91.09  92.31  378,106 
05/25/2023 95.19  95.73  90.59  92.54  1,070,973 
05/24/2023 88.00  96.12  85.30  95.36  3,472,925 
05/23/2023 79.63  80.91  78.40  79.22  678,278 
05/22/2023 79.99  81.51  77.74  79.42  939,345 
05/19/2023 82.29  83.33  79.84  79.98  1,133,956 
05/18/2023 81.40  81.99  79.17  81.19  952,410 
05/17/2023 85.00  85.32  81.96  82.04  501,066 
05/16/2023 83.67  86.80  80.30  85.02  798,288 
05/15/2023 86.06  86.56  83.60  84.60  634,590 
05/12/2023 87.87  88.18  83.44  85.63  767,000 
05/11/2023 88.41  89.96  85.02  88.01  1,070,205 
05/10/2023 89.50  92.20  76.56  90.38  5,040,928 
05/09/2023 103.84  106.61  103.53  105.37  570,252 
05/08/2023 104.37  105.98  100.91  104.78  574,734 
05/05/2023 103.30  105.29  102.87  104.79  570,951 
05/04/2023 101.42  102.63  99.76  102.40  480,487 
05/03/2023 100.72  104.36  99.99  102.04  621,073 
05/02/2023 99.58  100.93  98.02  99.84  328,269 
05/01/2023 98.00  101.36  98.00  99.79  291,219 
04/28/2023 97.89  99.62  96.51  98.86  309,439 
04/27/2023 98.82  98.92  96.21  98.23  417,900 

About Reata Pharmaceuticals Stock history

Reata Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Reata is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Reata Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Reata Pharmaceuticals stock prices may prove useful in developing a viable investing in Reata Pharmaceuticals
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. Reata Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Plano, Texas. Reata Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 346 people.

Reata Pharmaceuticals Stock Technical Analysis

Reata Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Reata Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Reata Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Bonds Directory Now

   

Bonds Directory

Find actively traded corporate debentures issued by US companies
All  Next Launch Module

Reata Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Reata Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Reata Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Reata to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in Reata Stock

If you are still planning to invest in Reata Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reata Pharmaceuticals' history and understand the potential risks before investing.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance